Otol Neurotol. 2024 Sep 1;45(8):939-946. doi: 10.1097/MAO.0000000000004275.
To report the natural history of vestibular schwannoma (VS) who elected an initial period of observation and identify prognostic factors. To describe the natural history of growing VS, identify prognostic factors, and review the most recent literature.
Prospective cohort study and literature review.
Tertiary referral center.
Adult patients diagnosed with a VS between January 1998 and February 2023.
Magnetic resonance imaging surveillance.
Growth-free survival and subsequent growth-free survival considering significant growth as a change in size of ≥2 mm.
Of 430 patients undergoing observation with serial magnetic resonance imaging, 193 (44.9%) demonstrated significant growth at a median of 1.6 years (interquartile range, 0.94-3.51). Of the 193 patients who presented an initial episode of growth, 137 elected to continue to be observed. Of those, 83 (60.6%) presented a second episode of growth at a median of 1.43 years (interquartile range, 1.00-2.49). The subsequent growth-free survival rates (95% confidence interval) at 1, 3, 5, 7, and 10 years were 91.79% (87.26-96.56%), 64.44% (56.56-73.42%), 52.52% (44.23-62.35%), 42.23% (33.92-52.56%), and 36.11% (27.89-46.76%), respectively. Univariate and multivariate Cox regression analyses showed that EC tumor location and initial growth rate were significant predictors of subsequent growth.
Close observation after documentation of growth is an appropriate management in well-selected cases given that only around 56% of the tumor will continue to grow. Extracanalicular tumor location and initial growth rate are promising prognostic factors to help determine which patient would be a better candidate for close surveillance after initial documentation of growth.
报告选择初始观察期的前庭神经鞘瘤(VS)的自然病史,并确定预后因素。描述生长性 VS 的自然病史,确定预后因素,并复习最新文献。
前瞻性队列研究和文献复习。
三级转诊中心。
1998 年 1 月至 2023 年 2 月期间诊断为 VS 的成年患者。
磁共振成像监测。
无进展生存期和考虑到显著生长(大小变化≥2mm)的后续无进展生存期。
在接受连续磁共振成像观察的 430 例患者中,193 例(44.9%)在中位数为 1.6 年(四分位距,0.94-3.51)时显示出显著生长。在最初出现生长的 193 例患者中,有 137 例选择继续观察。其中,83 例(60.6%)在中位数为 1.43 年(四分位距,1.00-2.49)时出现第二次生长。1、3、5、7 和 10 年的后续无进展生存率(95%置信区间)分别为 91.79%(87.26%-96.56%)、64.44%(56.56%-73.42%)、52.52%(44.23%-62.35%)、42.23%(33.92%-52.56%)和 36.11%(27.89%-46.76%)。单变量和多变量 Cox 回归分析表明,EC 肿瘤位置和初始生长率是后续生长的显著预测因素。
在选择良好的情况下,在记录生长后进行密切观察是一种合适的治疗方法,因为只有约 56%的肿瘤会继续生长。管外肿瘤位置和初始生长率是有前途的预后因素,可以帮助确定哪些患者在初始生长记录后更适合密切监测。